These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27306073)

  • 1. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
    Kochhar G; Singh T; Dust H; Lopez R; McCullough AJ; Liu X; Fung J; Shen B
    Inflamm Bowel Dis; 2016 Jul; 22(7):1670-8. PubMed ID: 27306073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control study.
    Mogl MT; Baumgart DC; Fischer A; Pratschke J; Pascher A
    Z Gastroenterol; 2018 Feb; 56(2):117-127. PubMed ID: 29212098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation.
    Wörns MA; Lohse AW; Neurath MF; Croxford A; Otto G; Kreft A; Galle PR; Kanzler S
    Am J Gastroenterol; 2006 Aug; 101(8):1931-7. PubMed ID: 16790037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Boardman L; Bruining DH; Lightner AL; Rosen CB; Heimbach JK; Hasan B; Poterucha JJ; Watt KD; Kane SV; Raffals LE; Loftus EV
    Inflamm Bowel Dis; 2018 Apr; 24(5):1074-1081. PubMed ID: 29522202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection.
    Verdonk RC; Haagsma EB; Van Den Berg AP; Karrenbeld A; Slooff MJ; Kleibeuker JH; Dijkstra G
    Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease.
    Verdonk RC; Dijkstra G; Haagsma EB; Shostrom VK; Van den Berg AP; Kleibeuker JH; Langnas AN; Sudan DL
    Am J Transplant; 2006 Jun; 6(6):1422-9. PubMed ID: 16686766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study.
    Ribaldone DG; Imperatore N; Le Grazie M; Furfaro F; Balestrieri P; De Blasio F; Fagoonee S; Mosso E; Boano V; Reggio D; Sarli E; Castiglione F; Milla M; Vecchi M; Saracco GM; Salizzoni M; Romagnoli R; Fiorino G; Astegiano M;
    Dig Liver Dis; 2021 Jun; 53(6):712-716. PubMed ID: 32972831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease following solid organ transplantation.
    Hampton DD; Poleski MH; Onken JE
    Clin Immunol; 2008 Sep; 128(3):287-93. PubMed ID: 18708022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation.
    Miki C; Harrison JD; Gunson BK; Buckels JA; McMaster P; Mayer AD
    Br J Surg; 1995 Aug; 82(8):1114-7. PubMed ID: 7648169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with
    Bajer L; Slavcev A; Macinga P; Sticova E; Brezina J; Roder M; Janousek R; Trunecka P; Spicak J; Drastich P
    World J Gastroenterol; 2018 Nov; 24(43):4939-4949. PubMed ID: 30487703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo inflammatory bowel disease after pediatric kidney or liver transplant.
    Fernandes MA; Braun HJ; Evason K; Rhee S; Perito ER
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27862714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
    Joshi D; Bjarnason I; Belgaumkar A; O'Grady J; Suddle A; Heneghan MA; Aluvihare V; Rela M; Heaton N; Agarwal K
    Liver Int; 2013 Jan; 33(1):53-61. PubMed ID: 22103794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states.
    Saigal S; Norris S; Srinivasan P; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2001 Jan; 7(1):11-5. PubMed ID: 11150415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study.
    Biselli M; Gramenzi A; Del Gaudio M; Ravaioli M; Vitale G; Gitto S; Grazi GL; Pinna AD; Andreone P; Bernardi M;
    J Clin Gastroenterol; 2010 Jan; 44(1):52-7. PubMed ID: 19581813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
    Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo inflammatory bowel disease after pediatric orthotopic liver transplant: a case report.
    Dehghani SM; Eshraghian A; Bahador A; Kakaei F; Geramizadeh B; Malek-Hosseini SA
    Exp Clin Transplant; 2009 Sep; 7(3):145-8. PubMed ID: 19715523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV
    Clin Transplant; 1996 Feb; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
    Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.